神经与癌症的相互作用 形状 质瘤 内瘤异质性
Tong Wu1,2, Peiran Zhao1, Zheng Chen2,3,4,5,6
1College of Smart Materials and Future Energy, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, 200438, P. R. China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|August 22, 2025
概括
质瘤细胞通过与大脑细胞的交流获得神经特征,增加瘤多样性和治疗耐药性. 了解这些神经癌症相互作用为质瘤异质性提供了新的治疗策略.
科学领域:
- 神经瘤学
- 癌症生物学
- 细胞神经科学
背景情况:
- 质瘤内异质性是有效癌症治疗的主要障碍,导致复发和治疗耐药性.
- 质瘤细胞表现出类似神经细胞的特征,这表明与神经细胞的沟通有助于瘤的功能多样性.
- 神经癌症相互作用在形成质瘤异质性的确切作用需要进一步的合成和概念化.
研究的目的:
- 为理解由神经癌症相互作用驱动的质瘤内异质性提出一个概念框架.
- 在空间背景下整合神经癌症相互作用的表型和转录证据.
- 突出这些相互作用在质瘤进展和治疗耐药性的关键作用.
主要方法:
- 结合了关于神经癌症相互作用的新证据.
- 专注于细胞表型 (神经质突触,网络,运动性) 和转录状态的概念框架的开发.
- 强调空间上下文,以链接表型和转录的发现.
主要成果:
- 质瘤细胞通过与神经细胞的沟通获得神经类型的表型和转录状态.
- 这些神经癌症相互作用会产生多样化的细胞表型,包括神经体突触和神经元类运动.
- 这些相互作用的协同效应推动了质瘤的进展,侵袭和对治疗的抵抗.
结论:
- 神经癌症相互作用在建立和维持质瘤内异质性方面起着至关重要的作用.
- 破坏这些相互作用是改善质瘤治疗结果的有希望的治疗策略.
- 需要对神经质瘤沟通的空间和分子机制进行进一步的研究.
更多相关视频
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
8.0K
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.6K
相关概念视频
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Cancer
51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
